3933 — United Laboratories International Holdings Share News
0.000.00%
Last trade - 00:00- HK$14.32bn
- HK$8.41bn
- CNY13.21bn
Brief: United Laboratories International Says NMPA Accepts Insulin Degludec And Liraglutide Injection Marketing Registration Application
Brief: United Laboratories International Posts HY Profit Attributable RMB 347.6 Million
China's United Laboratories half-year profit drops 82%
Brief: United Laboratories International Expects HY Net Profit RMB 340 Million
Brief: United Laboratories International Says FDA Approves IND Applications For UBT48128 Tablets
Brief: United Laboratories International Says China NMPA Approves United Lab Sodium Hyaluronate Eye Drops 0.3%
Brief: United Laboratories International China Approves United Laboratories' Tadalafil Tablets (5Mg, 10Mg, 20Mg) For Marketing
Brief: United Laboratories International Announces Retirement Of Fang Yu Ping As Executive Director
Brief: United Laboratories International To Buy Back Up To HK$200 Million Of Shares
Brief: United Laboratories International Says China NMPA Approves Clinical Trial Applications For Tul321 Capsules
Brief: United Laboratories International Says China NMPA Approves Clinical Trial Of Unit's TUL108
Brief: United Laboratories International Says Zhu Su Yan Resigns As Executive Director
Brief: United Laboratories International Says China's NMPA Approves Clinical Trial Application For UBT38006 Injection
Brief: United Laboratories International Says FDA Approves IND Application For TUl321 Capsules
Brief: United Laboratories International Says NMPA Approves Clinical Trial Application For Dupilumab Bio-Similar For Atopic Dermatitis
Brief: United Laboratories International Says Progress In Clinical Trial Of UBT251 Injection
Brief: United Laboratories International Declares Final Dividend Of RMB26 Cents Per Share
Brief: United Laboratories International Expects FY Profit RMB2 Bln
United Laboratories set to drop most in 11 months on forecasting FY profit decline